(Q40253271)

English

Antitumor activity of chimeric immunoreceptor gene-modified Tc1 and Th1 cells against autologous carcinoembryonic antigen-expressing colon cancer cells

scientific article published on 13 July 2006

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

Antitumor activity of chimeric immunoreceptor gene-modified Tc1 and Th1 cells against autologous carcinoembryonic antigen-expressing colon cancer cells (English)

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

1 reference

based on heuristic

inferred from title

author name string

Takeshi Sasaki

1

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

Hiroaki Ikeda

2

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

Masayoshi Sato

3

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

Takayuki Ohkuri

4

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

Hiroyuki Abe

5

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

Masahide Kuroki

6

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

Masafumi Onodera

7

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

Masaki Miyamoto

8

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

Satoshi Kondo

9

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

Takashi Nishimura

10

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

publication date

13 July 2006

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

97

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

9

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

920-927

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

A new era for cancer immunotherapy based on the genes that encode cancer antigens

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00271.X

21 January 2018

Cancer immunoediting: from immunosurveillance to tumor escape

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00271.X

21 January 2018

Normal development and function of CD8+ cells but markedly decreased helper cell activity in mice lacking CD4

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00271.X

21 January 2018

Helper activity is required for the in vivo generation of cytotoxic T lymphocytes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00271.X

21 January 2018

Progressive loss of CD8+ T cell-mediated control of a gamma-herpesvirus in the absence of CD4+ T cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00271.X

21 January 2018

MHC class II restricted tumor antigens and the role of CD4+ T cells in cancer immunotherapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00271.X

21 January 2018

Induction of a CD8+ cytotoxic T lymphocyte response by cross-priming requires cognate CD4+ T cell help

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00271.X

21 January 2018

CD40-independent pathways of T cell help for priming of CD8(+) cytotoxic T lymphocytes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00271.X

21 January 2018

Cognate CD4(+) T cell licensing of dendritic cells in CD8(+) T cell immunity

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00271.X

21 January 2018

CD4+ T cells are required for secondary expansion and memory in CD8+ T lymphocytes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00271.X

21 January 2018

Defective CD8 T Cell Memory Following Acute Infection Without CD4 T Cell Help

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00271.X

21 January 2018

CD4+ T cells are required for the maintenance, not programming, of memory CD8+ T cells after acute infection.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00271.X

21 January 2018

Help for cytotoxic-T-cell responses is mediated by CD40 signalling

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00271.X

21 January 2018

T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00271.X

21 January 2018

A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00271.X

21 January 2018

Immunologic tolerance maintained by CD25+ CD4+ regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00271.X

21 January 2018

Interleukin-12 and the regulation of innate resistance and adaptive immunity

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00271.X

21 January 2018

The critical role of Th1-dominant immunity in tumor immunology.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00271.X

21 January 2018

Critical role of the Th1/Tc1 circuit for the generation of tumor-specific CTL during tumor eradication in vivo by Th1-cell therapy.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00271.X

21 January 2018

Distinct role of antigen-specific T helper type 1 (Th1) and Th2 cells in tumor eradication in vivo

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00271.X

21 January 2018

The critical role of type-1 innate and acquired immunity in tumor immunotherapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00271.X

21 January 2018

Specific activation and targeting of cytotoxic lymphocytes through chimeric single chains consisting of antibody-binding domains and the gamma or zeta subunits of the immunoglobulin and T-cell receptors

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00271.X

21 January 2018

Generation and targeting of human tumor-specific Tc1 and Th1 cells transduced with a lentivirus containing a chimeric immunoglobulin T-cell receptor

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00271.X

21 January 2018

Natural selection of tumor variants in the generation of "tumor escape" phenotypes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00271.X

21 January 2018

Persistent Toll-like receptor signals are required for reversal of regulatory T cell-mediated CD8 tolerance

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00271.X

21 January 2018

Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00271.X

21 January 2018

Clinical significance of the determination of angiogenic factors

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00271.X

21 January 2018

Antigen-processing machinery breakdown and tumor growth

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00271.X

21 January 2018

Oxidative stress by tumor-derived macrophages suppresses the expression of CD3 zeta chain of T-cell receptor complex and antigen-specific T-cell responses

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00271.X

21 January 2018

Transduction of human CD34+ cells that mediate long-term engraftment of NOD/SCID mice by HIV vectors

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00271.X

21 January 2018

Rapid induction of tumor-specific type 1 T helper cells in metastatic melanoma patients by vaccination with mature, cryopreserved, peptide-loaded monocyte-derived dendritic cells.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00271.X

21 January 2018

Gene therapy of patient-derived T lymphocytes to target and eradicate colorectal hepatic metastases

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00271.X

21 January 2018

T cells engrafted with a recombinant anti-CD30 receptor target autologous CD30(+) cutaneous lymphoma cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00271.X

21 January 2018

The T-body approach: potential for cancer immunotherapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00271.X

21 January 2018

A chimeric receptor that selectively targets membrane-bound carcinoembryonic antigen (mCEA) in the presence of soluble CEA.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00271.X

21 January 2018

Identifiers

10.1111/J.1349-7006.2006.00271.X

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40253271&oldid=1891146203"